Stockscreener 앱 받기
0.4914
9.27%
0.0417
시간 외 거래:
.50
0.0086
+1.75%
Plus Therapeutics Inc 주식(PSTV)의 최신 뉴스
Navigating Biotech Innovation Amid Sector Volatility: High-Conviction Opportunities in 2025 - AInvest
Is a relief rally coming for Plus Therapeutics Inc. holdersJuly 2025 Price Swings & Reliable Momentum Entry Alerts - Newser
Can Plus Therapeutics Inc. hit a new high this monthTreasury Yields & Technical Pattern Based Buy Signals - Newser
Plus Therapeutics Inc. recovery potential after sell offTake Profit & Precise Swing Trade Entry Alerts - Newser
Plus Therapeutics Inc. stock trendline breakdownWeekly Loss Report & Free Real-Time Market Sentiment Alerts - Newser
Live market analysis of Plus Therapeutics Inc.Weekly Trend Recap & Daily Profit Maximizing Trade Tips - Newser
Plus Therapeutics, Inc. shares rise 2.22% premarket after HUTCHMED highlights clinical data at conference. - AInvest
Backtesting results for Plus Therapeutics Inc. trading strategiesGold Moves & Safe Capital Investment Plans - Newser
What is Plus Therapeutics Inc.’s valuation compared to sector2025 Sector Review & Weekly High Return Opportunities - خودرو بانک
Should you wait for a breakout in Plus Therapeutics Inc.2025 Big Picture & Daily Stock Trend Watchlist - Newser
How to read the order book for Plus Therapeutics Inc.Quarterly Market Summary & Verified Chart Pattern Signals - Newser
Visualizing Plus Therapeutics Inc. stock with heatmapsJuly 2025 Reactions & Verified Swing Trading Watchlist - Newser
Is Plus Therapeutics Inc. building a consolidation baseJuly 2025 Sentiment & Weekly Market Pulse Alerts - Newser
Multi asset correlation models including Plus Therapeutics Inc.Profit Target & AI Enhanced Trading Alerts - Newser
How to integrate Plus Therapeutics Inc. into portfolio analysis toolsOil Prices & AI Driven Price Forecasts - Newser
Screener Results Flag Plus Therapeutics Inc. as Oversold2025 Risk Factors & Community Verified Watchlist Alerts - beatles.ru
Plus Therapeutics, Inc. shares rise 1.96% intraday after AC Immune's operational efficiencies and pipeline focus. - AInvest
Using data tools to time your Plus Therapeutics Inc. exitQuarterly Earnings Summary & Smart Swing Trading Techniques - Newser
Tick level data insight on Plus Therapeutics Inc. volatilityEntry Point & AI Forecasted Entry/Exit Points - Newser
Published on: 2025-09-04 04:06:08 - Newser
Building trade automation scripts for Plus Therapeutics Inc.Jobs Report & Verified Swing Trading Watchlist - Newser
What data driven models say about Plus Therapeutics Inc.’s future2025 Stock Rankings & Free Verified High Yield Trade Plans - Newser
Can machine learning forecast Plus Therapeutics Inc. recovery2025 Fundamental Recap & Smart Allocation Stock Tips - Newser
How to forecast Plus Therapeutics Inc. trends using time seriesJuly 2025 Market Mood & Technical Pattern Recognition Alerts - Newser
Chart overlay techniques for tracking Plus Therapeutics Inc.July 2025 Levels & Real-Time Chart Breakout Alerts - Newser
Plus Therapeutics shares rise 4.68% intraday after announcing participation in H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
Plus Therapeutics stock rating upgraded to Buy by D. Boral Capital - Investing.com Canada
This BorgWarner Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday - Benzinga
Market reaction to Plus Therapeutics Inc.’s recent news2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Custom watchlist performance reports with Plus Therapeutics Inc2025 Historical Comparison & Weekly Watchlist for Hot Stocks - Newser
Plus Therapeutics Inc. stock momentum explainedMarket Weekly Review & Expert Curated Trade Ideas - Newser
Will Plus Therapeutics Inc. stock hit new highs in YEARWeekly Profit Recap & Capital Protection Trading Alerts - khodrobank.com
What Fibonacci levels say about Plus Therapeutics Inc. rebound2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
What technical models suggest about Plus Therapeutics Inc.’s comebackWeekly Stock Analysis & Free Community Supported Trade Ideas - Newser
What moving averages say about Plus Therapeutics Inc.2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Plus Therapeutics, Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference 2025 - Quiver Quantitative
Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
CNS Cancer Drug Developer Plus Therapeutics Featured at Major H.C. Wainwright Investment Conference - Stock Titan
Ranking Plus Therapeutics Inc. among high performing stocks via toolsJuly 2025 Macro Moves & Real-Time Volume Triggers - Newser
What is Plus Therapeutics Inc. s revenue forecastTrade Performance Summary & High Accuracy Swing Trade Signals - خودرو بانک
Custom watchlist performance reports with Plus Therapeutics Inc.2025 Technical Overview & Safe Capital Growth Tips - Newser
Guidance Update: Is now the right time to enter Plus Therapeutics Inc.Weekly Earnings Recap & Risk Managed Trade Strategies - خودرو بانک
Is Plus Therapeutics Inc. stock reversal real or fakeWeekly Profit Summary & Fast Exit and Entry Strategy Plans - Newser
What is the long term forecast for Plus Therapeutics Inc. stock2025 Winners & Losers & Community Verified Trade Alerts - خودرو بانک
1.40%
자본화:
|
볼륨(24시간):